Where industry leaders will share insights on implementing and scaling AI across the pharmaceutical value chain.
AI in pharma and healthcare has moved beyond the hype, entering a critical phase of adoption and scale. The focus is no longer on whether AI works, it’s about embedding it at scale to transform every stage of healthcare operations. From accelerating drug discovery to streamlining clinical trials and personalizing patient engagement, AI holds the key to reshaping the healthcare industry.
The 2025 AI for Pharma and Healthcare Conference is designed to tackle these challenges head-on, providing actionable insights, real use cases and practical strategies for scaling AI effectively.
Join Us for Innovative Discussions on
Navigating AI Adoption: Gain the insights and strategies needed to navigate the complexities of scaling AI integration, from ethical considerations and AI literacy to regulatory constraints
Drug Discovery at Scale: From target identification to precision screening, AI has proven its value. The next step is scaling these breakthroughs to reduce timelines and boost success rates across the drug development pipeline
Clinical Trials 2.0: AI is streamlining patient recruitment, trial management, and real-world evidence collection. The conference will explore how to make AI-powered trials the norm, optimizing efficiency and compliance
Commercial Strategies: AI-driven tools are revolutionising patient engagement and marketing. Scaling these solutions enables pharma companies to deliver targeted therapies and create long-term value at an unprecedented scale
Why is now the time to join the discussion?
AI for Pharma & Healthcare is brought to you at a critical time for innovation, as the below demonstrates the rate of innovation, size of current market and critical importance to stay at the cusp of latest technologies and innovations.
95% Of pharmaceutical companies reported that they are investing in AI capabilities.
70% That's how much AI could reduce the cost of discovering new drugs.
$187.95Bn The estimated growth of the AI in healthcare market by 2030.
88% Of pharmaceutical companies see AI as crucial for achieving operational efficiencies.
Very valuable to get an insight what other companies are planning, what challenges they have and discuss possible solutions
Great value event, enjoyed networking and the latest thinking from like minded professionals
Great experience. Benchmarking and networking opportunities was great! Especially liked the What IF scenarios and discussions around that
2025 Speaker Faculty
Galina Gray, SVP Digital Transformation, Bayer
Zhaoling Meng, AVP, Global Head Clinical Modeling & Evidence Integration, Digital and Data Sciences, Sanofi
Shameer Khader, Executive Director - Precision Medicine and Computational Biology, Sanofi
Sean Buckley, Chief Information Officer, Immunocore
Rajvir Madan, Chief Digital and Information Technology Officer, Arcutis Biotherapeutics
Thirupathi Pattipaka, Global Director, DataScience & AI, Novartis
Christos Varsakelis, Associate Director of AI & ML, Janssen
Dr Zara Ghazoui, Director, Digital Innovation, Oncology Medical, AstraZeneca
Cedric Berger, President, Roche
Nishtha Jain, Head of Innovation and Digital Technology, Takeda
Émilie Louvet, AstraZeneca, Director Regulatory Data Products, Digital Regulatory, Regulatory Affairs
Julia Chernova, Digital Health Expert, Bayer Pharmaceuticals
Cedric Verschueren, Head of Ethics & Business Integrity, Sanofi
